These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 3659250

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Influence of activated charcoal on the pharmacokinetics and the clinical features of carbamazepine poisoning.
    Brahmi N, Kouraichi N, Thabet H, Amamou M.
    Am J Emerg Med; 2006 Jul; 24(4):440-3. PubMed ID: 16787802
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Severe theophylline intoxication: a delay in charcoal haemoperfusion solved by oral activated charcoal.
    Rutten J, van den Berg B, van Gelder T, van Saase J.
    Nephrol Dial Transplant; 2005 Dec; 20(12):2868-9. PubMed ID: 16115857
    [No Abstract] [Full Text] [Related]

  • 25. Continuous nasogastric administration of activated charcoal for the treatment of theophylline intoxication.
    Ohning BL, Reed MD, Blumer JL.
    Pediatr Pharmacol (New York); 1986 Dec; 5(4):241-5. PubMed ID: 3737269
    [Abstract] [Full Text] [Related]

  • 26. Acute valproic acid intoxication: enhanced drug clearance with oral-activated charcoal.
    Farrar HC, Herold DA, Reed MD.
    Crit Care Med; 1993 Feb; 21(2):299-301. PubMed ID: 8428486
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Decreased phenobarbital absorption with charcoal administration for chronic renal failure.
    Tanaka C, Yagi H, Sakamoto M, Koyama Y, Ohmura T, Ohtani H, Sawada Y.
    Ann Pharmacother; 2004 Jan; 38(1):73-6. PubMed ID: 14742799
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. An evaluation of the effect of repeated doses of oral activated charcoal on the depletion of enrofloxacin residual levels in chicken breast muscles.
    Abd El-Aty AM, Choi JH, Park JH, Shim JH.
    Berl Munch Tierarztl Wochenschr; 2007 Jan; 120(5-6):210-4. PubMed ID: 17555041
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Out-of-hospital administration of activated charcoal by emergency medical services.
    Alaspää AO, Kuisma MJ, Hoppu K, Neuvonen PJ.
    Ann Emerg Med; 2005 Feb; 45(2):207-12. PubMed ID: 15671978
    [Abstract] [Full Text] [Related]

  • 34. Factors influencing the clinical efficacy of activated charcoal.
    Watson WA.
    Drug Intell Clin Pharm; 1987 Feb; 21(2):160-6. PubMed ID: 3549212
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Container residue after activated charcoal administration in the emergency department.
    Harchelroad F.
    Vet Hum Toxicol; 1992 Feb; 34(1):13-4. PubMed ID: 1621355
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Increased serum theophylline clearance with orally administered activated charcoal.
    Mahutte CK, True RJ, Michiels TM, Berman JM, Light RW.
    Am Rev Respir Dis; 1983 Nov; 128(5):820-2. PubMed ID: 6638669
    [Abstract] [Full Text] [Related]

  • 39. Haemodialysis with charcoal haemoperfusion.
    Winchester JF, Apiliga MT, Mackay JM, Kennedy AC.
    Proc Eur Dial Transplant Assoc; 1976 Nov; 12():526-33. PubMed ID: 935131
    [Abstract] [Full Text] [Related]

  • 40. Accelerated clearance of intravenously administered theophylline and phenobarbital by oral doses of activated charcoal in rats. A possibility of the intestinal dialysis.
    Arimori K, Nakano M.
    J Pharmacobiodyn; 1986 May; 9(5):437-41. PubMed ID: 3761133
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.